Abstract
In the last few years, considerable interest has been generated in the role of high-mobility-group (HMG) proteins, and HMG box proteins generally, in cancer development and therapy. These proteins were discovered in the early 1970s (Goodwin et al. 1973) as a group of nonhistone proteins. Some members of the HMG protein family (i) constitute a class of important architectural proteins involved in transcriptional regulation of genes, (ii) are frequently expressed in transformed cells at levels that correlate with the degree of neoplastic cell transformation, (iii) participate in gene rearrangements, which are linked to the emergence of benign solid tumors, (iv) confer the ability to recognize DNA-cisplatin adducts selectively, and (v) provide a new delivery system for efficient gene transfer. It should be considered that some HMG proteins, acting as architectural proteins that bring many of the transcription factors into precise three-dimensional shapes, may have a similar critical role in neoplastic-transformation to that of some transcription factors themselves.
References
Aizawa S, Nishino H, Saito K, Kimura K, Shirakawa H, Yoshida M (1994) Stimulation of transcription in cultured cells by high mobility group protein 1: essential role of the acidic carboxylterminal region. Biochemistry 33: 14690–14695
Arnold W, Böttger M, Hauff P, Rudolph M, Scherneck S (1992) Neoplastic changes in HPV 11 and HPV 11 DNA/HMG1 complex-infected human foreskin tissues using subrenal capsule technique in nude andscid mice. Contrib Oncol 42: 294–302
Ashar HR, Schoenberg Fejzo M, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC, Chada K (1995) Disruption of the architectural factor HMGI-C: DNA binding AT motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82: 57–65
Ashar HR, Cherath L, Przybysz KM, Chada K (1996) Genomic characterization for human HMGIC, a member of the accessory transcription factor family found at translocation breakpoints in lipomas. Genomics 31: 207–214
Baxevanis AD, Landsman D (1995) The HMG box protein family: classification and functional relationships. Nucleic Acids Res 23:1604–1613
Behrens J, von Kries JP, Kühl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W (1996) Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382: 638–642
Bellon SF, Coleman JH, Lippard SJ (1991) DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drugcis-diamminedichloroplatinum (II). Biochemistry 30: 8026–8035
Berlingieri MT, Manfioletti G, Santoro M, Bandiera A, Visconti R, Giancotti V, Fusco A (1995) Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol 15: 1545–1553
Bianchi ME (1991) Production of functional rat HMG1 protein inEscherichia coli. Gene 104: 271–275
Böttger M, Vogel F, Platzer M, Kiessling U, Grade K, Strauss M (1988) Condensation of vector DNA by the chromosomal protein HMG1 results in efficient transfection. Biochim Biophys Acta 950: 221–228
Böttger M, Platzer M, Kiessling U, Strauss M (1990) Transfection by DNA-nuclear protein HMG1 complexes: raising of efficiency and role of DNA topology. Arch Geschwulstforsch 60: 265–270
Böttger M, Arnold W, Zaitsev S, Vorob'ev VI, Haberland A, Schimke I (1996) HMG1-effected gene transfer using cell cultures and tissue explants xenografted in immunodeficient mice. Contrib Oncol 51: 36–40
Brown SJ, Kellett PJ, Lippard SJ (1993) Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin. Science 261: 603–605
Bruhn SL, Pil PM, Essigmann JM, Housman DE, Lippard SJ (1992) Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin. Proc Natl Acad Sci USA 89: 2307–2311
Bussemakers MJG, WJM van de Ven, Debruyne FMJ, Schalken SA (1991) Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res 51: 606–611
Bustin M, Lehn DA, Landsman D (1990) Structural features of the HMG chromosomal proteins and their genes. Biochim Biophys Acta 1049: 231–243
Bustin M, Trieschmann L, Postnikov YV (1995) The HMG-14/-17 chromosomal protein family: architectural elements that enhance transcription from chromatin templates. Semin Cell Biol 6: 247–255
Chau K-Y, Patel UA, Lee K-LD, Lam H-YP, Crane-Robinson C (1995) The gene for the human architectural transcription factor HMGI-C consists of five exons each coding for a distinct functional element. Nucleic Acids Res 23: 4262–4266
Chiappetta G, Bandiera A, Berlingieri MT, Visconti R, Manfioletti G, Battista S, Martinez-Tello FJ, Santoro M, Giancotti V, Fusco A (1995) The expression of the high mobility group HMGI(Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene 10: 1307–1314
Cleaver JE, Hultner ML (1995) Transcription-related human disorders. Am J Hum Genet 56: 1257–1261
Dzau VJ, Morishita R, Gibbons GH (1993) Gene therapy for cardiovascular disease. Trends Biotechnol 11: 205–210
Fedele M, Bandiera A, Chiappetta G, Battista S, Viglietto G, Manfioletti G, Casamassimi A, Santoro M, Giancotti V, Fusco A (1996) Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res 56: 1896–1901
Gaillard C, Strauss F (1994) Association of poly (CA)·poly (TG) DNA fragments into four-stranded complexes bound by HMG 1 and 2. Science 264: 433–436
Giancotti V, Berlingieri MT, Di Fiore PP, Fusco A, Vecchio G, Crane-Robinson C (1985) Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus. Cancer Res 45: 6051–6057
Giancotti V, Pani B, D'Andrea P, Berlingieri MT, Di Fiore PP, Fusco A, Vecchio G, Philp R, Crane-Robinson C, Nicolas RH, Wright CA, Goodwin GH (1987) Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by co-transfection with c-myc and polyoma middle T genes. EMBO J 6: 1981–1987
Giancotti V, Buratti E, Perissin L, Zorzet S, Balmain A, Portella G, Fusco A, Goodwin GH (1989) Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp Cell Res 184: 538–545
Giancotti V, Bandiera A, Ciani L, Santoro D, Crane-Robinson C, Goodwin GH, Boiocchi M, Dolcetti R, Casetta B (1993) Highmobility-group (HMG) proteins and histone H1 subtypes expression in normal and tumor tissues of mouse. Eur J Biochem 213: 825–832
Giese K, Cox J, Grosschedl R (1992) The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69: 185–195
Goodwin GH, Sanders C, Johns EW (1973) A new group of chromatinassociated proteins with a high content of acidic and basic amino acids. Eur J Biochem 38: 14–19
Grossbach U (1995) Selective distribution of histone H1 variants and high mobility group proteins in chromosomes. Semin Cell Biol 6: 237–246
Grosschedl R, Giese K, Pagel J (1994) HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet 10: 94–100
Henderson D, Hurley LH (1995) Molecular struggle for transcriptional control. Nat Med 1: 525–527
Hesketh R (1995) The oncogene facts book. Academic Press, London San Diego New York
Hughes EN, Engelsberg BN, Billings PC (1992) Purification of nuclear proteins that bind to cisplatin-damaged DNA. Identity with high mobility group proteins 1 and 2. J Biol Chem 267: 13520–13527
Jantzen H-M, Admon A, Bell SP, Tjian R (1990) Nucleolar transcription factor hUBF contains a DNA-binding motif with homology to HMG proteins. Nature 344: 830–836
John S, Reeves RB, Lin J-X, Child R, Leiden JM, Thompson CB, Leonard WJ (1995) Regulation of cell-type-specific interleukin-2 receptor α-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kB family proteins. Mol Cell Biol 15: 1786–1796
Johns EW (ed) (1982) The HMG chromosomal proteins. Academic Press, Orlando, Fla
Kaneda Y, Iwai K, Uchida T (1989) Increased expression of DNA conintroduced with nuclear protein in adult rat liver. Science 243: 375–378
Kato K, Nakanishi M, Kaneda Y, Uchida T, Okada Y (1991) Expression of hepatitis B virus surface antigen in adult liver: co-introduction of DNA and nuclear protein by a simplified liposome method. J Biol Chem 266: 3361–3364
Kazmierczak B, Hennig Y, Wanschura S, Rogalla P, Bartnitzke S, Van de Ven W, Bullerdiek J (1995) Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene. Cancer Res 55: 6038–6039
Kazmierczak B, Rosigkeit J, Wanschura S, Meyer-Bolte K, Van de Ven W, Kayser K, Krieghoff B, Kastendiek H, Bartnitzke S, Bullerdiek J (1996) HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors. Oncogene 12: 515–521
Leger H, Sock E, Renner K, Grummt F, Wegner M (1995) Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-I/Y. Mol Cell Biol 15: 3738–3747
Lehming N, Thanos D, Brickman JM, Ma J, Maniatis T, Ptashne M (1994) An HMG-like protein that can switch a transcriptional activator to a repressor. Nature 371: 175–179
Lewis H, Kaszubska W, DeLamarter JF, Whelan J (1994) Cooperativity between two NF-kB complexes, mediated by high-mobility-group protein I(Y), is essential for cytokine-induced expression of the E-selectin promoter. Mol Cell Biol 14: 5701–5709
Love JJ, Li X, Case DA, Giese K, Grosschedl R, Wright PE (1995) Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature 376: 791–795
Lund T, Holtlund J, Fredriksen M, Laland SG (1983) On the presence of two new high mobility group-like proteins in HeLa S3 Cells. FEBS Lett 152: 163–167
MacLeod MC, Powell KL, Tran N (1995) Binding of the transcription factor, SP1, to non-target sites in DNA modified by benzo[a]pyrene diol epoxide. Carcinogenesis 16: 975–983
Manfioletti G, Giancotti V, Bandiera A, Buratti E, Sautière P, Cary P, Crane-Robinson C, Coles B, Goodwin GH (1991) cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res 19: 6793–6797
McA'Nulty MM, Lippard SJ (1996) The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast. Mutat Res 362: 75–86
Ner SS, Travers AA, Churchill MEA (1994) Harnessing the writhe: a role for DNA chaperones in nucleoprotein-complex formation. Trends Biochem Sci 19: 185–187
Ogram SA, Reeves R (1995) Differential regulation of a multipromoter gene. Selective 12-O-tetradecanoylphorbol-13-acetate induction of a single transcription start site in theHMGI/Y gene. J Biol Chem 270: 14235–14242
Patel UA, Bandiera A, Manfioletti G, Giancotti V, Chau K-Y, Crane-Robinson C (1994) Expression and cDNA cloning of human HMGI-C phosphoprotein. Biochem Biophys Res Commun 201: 63–70
Rabbitts TH (1994) Chromosomal translocations in human cancer. Nature 372: 143–149
Ram TG, Reeves R, Hosick HL (1993) Elevated high mobility group I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res 53: 2655–2660
Read CM, Cary PD, Crane-Robinson S, Driscoll PC, Carrillo MOM, Norman DG (1995) The structure of the HMG box and its interaction with DNA. In: Eckstein F, Lilley DMJ (eds) Nucleic acids and molecular biology 9: 222–250
Sandig V, Stamm W, Behlke J, Böttger M, Strauss M (1995) Direct gene transfer of HMG1 based DNA-protein complexes (abstract). J Mol Med 73: B10
Schoenmakers EFPM, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJM (1995) Recurrent rearrangements in the high mobility group protein gene,HMGI-C in benign mesenchymal tumours. Nat Genet 10: 436–444
Sheridan PL, Sheline CT, Cannon K, Voz ML, Pazin MJ, Kadonaga JT, Jones KA (1995) Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes Dev 9: 2090–2104
Shirakata M, Hüppi K, Usuda S, Okazaki K, Yoshida K, Sakano H (1991) HMG1-related DNA-binding protein isolated with V-(D)-J recombination signal probes. Mol Cell Biol 11: 4528–4536
Takahara PM, Rosenzweig MC, Frederick CA Lippard SJ (1995) Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Nature 377: 649–652
Thanos D, Maniatis T (1992) The high mobility group protein HMGI(Y) is required for NFkB-dependent virus induction of the human IFNβ gene. Cell 71: 777–789
Thanos D, Maniatis T (1995) Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome. Cell 83: 1091–1100
Tmimi Y, van der Poel HG, Denyn MM, Umbas R, Karthaus HFM, Debruyne FMJ, Shalken JA (1993) Increased expression of high mobility group protein I(Y) in high grade prostate cancer determined by in situ hybridization. Cancer Res 53: 5512–5516
Treiber DK, Zhai X, Jantzen H-M, Essigmann JM (1994) Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor). Proc Natl Acad Sci USA 91: 5672–5676
Tricoli JV, Yao JL, D'Souza SA, Bracken RB (1993) Detection of sex-region Y (SRY) transcripts in human prostate adenocarcinoma and benign prostatic hypertrophy. Genes Chromosomes Cancer 8: 28–33
Verbeek S, Izon D, Hofhuis F, Robanus-Maandag E, de Riele H, van de Wetering M, Oosterwegel M, Wilson A, Robson MacDonald H, Clevers H (1995) An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature 374: 70–74
Wagner JP, Quill DM, Pettijohn DE (1995) Increased DNA-bending activity and higher affinity DNA binding of high mobility group protein HMG-1 prepared without acids. J Biol Chem 270: 7394–7398
Wanschura S, Schoenmakers EFPM, Huysmans C, Bartnizke S, Van de Ven WJM, Bullerdiek J (1996) Mapping of the gene encoding the human hepatoma-derived growth factor (HDGF) with homology to the high-mobility group (HMG)-1 protein to Xq25. Genomics 32: 298–300
Watanabe F, Shirakawa H, Yoshida M, Tsukada K, Teraoka H (1994) Stimulation of DNA-dependent protein kinase activity by high mobility group proteins 1 and 2. Biochem Biophys Res Commun 202: 736–742
Werner MH, Gronenborn AM, Clore GM (1996) Intercalation, DNA kinking, and the control of transcription. Science 271: 778–784
Wood LD, Farmer AA, Richmond A (1995) HMGI(Y) and Sp1 in addition to NF-kB regulate transcription of the MGSA/GROα gene. Nucleic Acids Res 23: 4210–4219
Yamazaki F, Nagatsuka Y, Shirakawa H, Yoshida M (1995) Repression of cell cycle progression by antisense HMG2 RNA. Biochem Biophys Res Commun 210: 1045–1051
Zamble DB, Lippard SJ (1995) Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem Sci 20: 435–439
Zhou X, Benson KF, Ashar HR, Chada K (1995) Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376: 771–774
Author information
Authors and Affiliations
Corresponding author
Additional information
Dedicated to Professor Erich Hecker on the occasion of his 70th birthday
Rights and permissions
About this article
Cite this article
Wunderlich, V., Böttger, M. High-mobility-group proteins and cancer—an emerging link. J Cancer Res Clin Oncol 123, 133–140 (1997). https://doi.org/10.1007/BF01214665
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01214665